Wegovy, a semaglutide-based weight loss drug, has become a vital option for people in the UK seeking medical support for their illness. obesityespecially following recent price increases for alternatives like Mounjaro. As more people turn to private healthcare providers amid delays in the NHS and stricter eligibility, it is more important than ever to understand current pricing, access routes and the benefits of different pharmacy options.
Wegovy price trend in 2025
In the UK, there will be notable changes in the weight loss drug market in 2025, mainly due to the significant increase in Mounjaro prices in September. Mounjaro’s highest dose currently costs as much as £384, while Wegovy’s prices remain relatively stable across most private providers. Typical costs for Wegovy pens at major box stores and online pharmacies are:
- 0.25mg/0.5mg/1mg starter pens: approximately £103 to £118 each
- 1.7mg pen: approximately £175 to £178 per pen
- Maximum dose 2.4mg: approximately £188 to £245 per pen (depending on provider)
Important changes are occurring as cost pressures increase. Wegovy, which was previously slightly cheaper than Mounjaro, is now consistently the more affordable and accessible option of the two, particularly for private patients who do not meet strict NHS criteria.
SheMed’s £89 Wegovy offer: Best on the market
Among all the online clinics and high street pharmacies in the UK, SheMed stands out with its attractive offer. Wegovy costs just £89 for your first month, including a starter package that includes blood tests and personalized support. Compared to prices starting from £103 to £189 for other providers, this will be the most affordable entry point for those getting started with Wegovy in the UK market as of October 2025.
This offer is more than just a low initial price. From the introductory month onwards, SheMed’s ongoing cost is a transparent £159 per month, with no hidden extra charges for higher doses as patients progress through their weight loss journey. This predictability makes financial planning easier and distinguishes SheMed from other pharmacies that charge up to £245 for Wegovy’s highest strength.
Compare SheMed to other pharmacies
Pharmacy prices vary based on supply, prescription costs, and clinical support packages; Seamed This model is both affordable and reliable. Quick comparison:
| provider | First month fee | Ongoing monthly fee | highest dose price | hidden charges | support package |
| Seamed | £89 | £159 | £159 | none | Blood test + 24/7 care |
| large scale online clinic | £103 – £130 | £145 – £215 | £175 – £245 | sometimes | Standard (various) |
| high street pharmacy | £118 – £189 | £148 – £245 | £178 – £245 | sometimes | standard |
This table shows that SheMed’s induction fees are at least £30-60 lower than its competitors, with the added benefit of blood tests and ongoing side effects care at no extra cost. Additionally, SheMed’s prices remain the same as patients increase their dosage, a common scenario at other pharmacies where costs rise quickly.
Wegovy availability in the NHS: opportunities and delays
Wegovy is technically NHS for weight managementthe reality for most candidates involves long wait times and rigorous qualifications. NHS approval is based on National Institute for Health and Care Excellence (NICE) guidelines and requires:
- Have a BMI of 35 or higher and at least one weight-related health condition (diabetes, hypertension, etc.)
- Referral to a specialist weight management service rather than a direct prescription from a general practitioner
- Evidence of failure of diet and lifestyle therapy
Waiting lists often stretch for months or longer, especially in areas where specialist services are overburdened. There is also a cap on the number of prescriptions NHS weight management teams can issue due to funding allocation and supply constraints.
Private providers are quickly becoming the go-to option for people who don’t exactly meet NHS standards, or who simply want a faster, less bureaucratic route. Private access includes online or in-person clinical assessment and, if necessary, prescriptions filled directly by the pharmacy without a backlog of referrals.
Why Private Access (and SheMed) Makes Sense
NHS waiting times are unpredictable, and given Wegovy’s strict eligibility criteria for private services, it has attracted attention for the following reasons:
- Speed: Most private clinics offer consultations and prescriptions in the same week, so patients can start treatment right away.
- Wider audience: Private pharmacies accept a wider range of BMI and comorbidity profiles than the NHS, and provide treatment to more people who are excluded from medical assistance.
- Ongoing medical support: Reputable private providers, including SheMed, include regular progress reviews, side effect support, prescription adjustments, and often have a dedicated clinical team available online.
While NHS access is ideal for those who are eligible and have the patience to endure waiting lists, private access, especially at a competitive price, provides a viable and reliable alternative for immediate support, allowing more people to benefit from proven GLP-1 therapies.
How price changes will impact UK patients
The recent price increase for Munjaro has further widened the cost difference between weight loss drugs. Currently, Mounjaro charges up to £384 per dose at its highest strength and Wegovy remains stable, so patients, especially those who are funding their own treatment, can make significant savings by moving to Wegovy, especially through a lower-cost provider such as SheMed.
Additionally, the price remains stable after the first month, so patients do not face any unwanted surprises as their prescription increases. This is a common scenario in weight loss programs aiming for lasting results.
Key points for UK consumers
- Wegovy is now the best value weight loss drug on the UK market, especially after the price hike for Mounjaro.
- Private access to Wegovy costs a monthly fee but is faster, more flexible and more comprehensive than the NHS route.
- SheMed’s £89 introductory offer includes transparent ongoing pricing and strong patient care, leading the market in value and reliability.
- The NHS remains an important route for patients who qualify and can wait, but for many patients, SheMed and similar clinics offer a faster, easier and more predictable path to effective medical weight management.
Eligibility, safety and clinical oversight considerations remain important for all weight loss drugs, but the savvy UK consumer in 2025 will find that Wegovy (particularly through SheMed’s £89 contract) offers the best balance of price, reliability and support across both the NHS and private healthcare sectors.
Source: Our Culture – ourculturemag.com
